JPRN-UMIN000029360已完成未知
sefulness of topical heparinoid in the treatment of asteatosis in hemodialyzed patients - Usefulness of topical heparinoid in the treatment of asteatosis in hemodialyzed patients
ippon medical school hospital0 个研究点目标入组 76 人开始时间: 2017年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 76
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients who received heparinoid- or urea -containing drugs, or petrolatum within three weeks before signing the consent form. (2) Patients with/ with the past of extensive complications of the skin (burn, psoriasis etc.) (3) Patients with allergy to heparinoid (4) Patients with hemorrhagic blood disease (hemophilia, thrombocytopenia, purpura etc.) (5) Patients who are expected a few bleeding causes a serious result. (6) Patients who are pregnant, or possibly pregnant women. (7)Patients who participated in other clinical study within 4 months before starting study. (8) Patients who are unsuitable to the study at the investigator's discretion.
研究者
相似试验
已完成
不适用
Examination of usefulness and safety of heparinoid agent based external medicine (over counter drug) for facial dryness symptom.JPRN-UMIN000018986Osaka city university graduate school of medicine, department of dermatology50
尚未招募
3 期
To test whether application of topical heparin solution around the IV cannula site daily would reduce the occurrence of superficial inflammation of veins when compared to a placeboCTRI/2024/06/069653All India Institute of Medical Sciences, Mangalagiri
已完成
1 期
Prevention of local skin reaction by heparinoid due to rotigotine transdermal patch: a pilot randomized clinical trial.Parkinson's diseases diseaseJPRN-UMIN000033409Wakayama Medical University20
招募中
3 期
The efficacy of topical Hydroquinon with and without using Erbium YAG LASER in treatment of melasmaMelasma.L81.1ChloasmaIRCT20181201041812N1Tehran University of Medical Sciences27
已完成
不适用
Effect OF Heparin solution for prevention of pain and swelling at the site of peripheral intravenous catheter.CTRI/2017/10/010089PARUL INSTITUTE OF MEDICAL SCIENCE AND RESEARCH100